Login
$IMRX
$3.83 +$0.12 (3.23%) Close

$IMRX 8-K/A SEC Filings

Filed On Filing
02 Oct 2024 8-K/A: Departure/Election of Directors or Officers; Compensation

On March 14, 2024, Immuneering Corporation (the “Company”) filed a Current Report on Form 8-K (the “Initial 8-K”) disclosing that the Board of Directors of the Company (the “Board”) elected Thomas J. Schall, Ph.D. to the Board as a Class...

19 Sep 2022 8-K/A: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support